Want to join the conversation?
For FY17, $STE expects revenue growth of 25-26%, including approx. 7% organic revenue growth. Adjusted net diluted EPS is expected to be $3.85-4.00. $STE expects $15MM in cost synergies from the combination with Synergy and an adjusted effective tax rate of approx. 25%. Free cash flow will be about $250MM and Capex will be about $190MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?